Filipppo de Braud
Internal medicineOncologyRandomized controlled trialPlaceboCombination therapyNeuroendocrine tumorsPasireotideSunitinibLanreotideEverolimusMedicine
Publications 1
#1Sara PuscedduH-Index: 18
#2Antonio Facciorusso (University of Foggia)H-Index: 19
view all 16 authors...
Although combination therapy is not recommended in patients with gastro-entero-pancreatic (GEP) neuroendocrine tumors (NETs), this strategy is widely used in clinical practice. This network meta-analysis of randomized trials evaluates targeted therapies and somatostatin analogues in GEP advanced NETs, either alone or in combination, comparing the efficacy of different single or combined treatment strategies in terms of progression-free survival (PFS). Interventions were grouped as analogues, eve...